These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6287725)

  • 1. [Circulating immunocomplexes in lung neoplasms].
    Pesek M; Sefrna F; Simecek C; Racek J
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunocomplexes and primary lung cancer.
    Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
    Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 6. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor associated antigen with pulmonary neoplasms.
    Lo Gerfo P; Herter FP; Braun J; Hansen HJ
    Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of the secretory immune system to bronchogenic carcinoma of the lung.
    Iglehart JD; Montelaro RC; Bolognesi DP; Sabiston DC; Wolfe WG
    Surg Forum; 1979; 30():118-9. PubMed ID: 231845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic status in lung cancer.
    Brugarolas A; Takita H
    Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-associated antigens in lung cancer: the possibility for a serologic assay.
    Kelly BS; Levy JG
    Can Med Assoc J; 1980 May; 122(9):1020-3. PubMed ID: 7370881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.